Authors:
Mulder, HJGH
Schalij, MJ
Kauer, B
Visser, RF
van Dijkman, PRM
Jukema, JW
Zwinderman, AH
Bruschke, AVG
Citation: Hjgh. Mulder et al., Pravastatin and endothelium dependent vasomotion after coronary angioplasty: the PREFACE trial, HEART, 86(5), 2001, pp. 533-539
Authors:
van de Poll, SWE
Romer, TJ
Volger, OL
Delsing, DJM
Schut, TCB
Princen, HMG
Havekes, LM
Jukema, JW
van der Laarse, A
Puppels, GJ
Citation: Swe. Van De Poll et al., Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice, ART THROM V, 21(10), 2001, pp. 1630-1635
Citation: P. Steendijk et al., Hypertonic saline method accurately determines parallel conductance for dual-field conductance catheter, AM J P-HEAR, 281(2), 2001, pp. H755-H763
Citation: Rj. Nederhand et al., Factor VII polymorphisms and myocardial infarction: What is special in italians?, THROMB HAEM, 85(4), 2001, pp. 746-747
Authors:
Agema, WRP
Jukema, JW
Pimstone, SN
Kastelein, JJP
Citation: Wrp. Agema et al., Genetic aspects of restenosis after percutaneous coronary interventions - Towards more tailored therapy, EUR HEART J, 22(22), 2001, pp. 2058-2074
Authors:
Clee, SM
Zwinderman, AH
Engert, JC
Zwarts, KY
Molhuizen, HOF
Roomp, K
Jukema, JW
van Wijland, M
van Dam, M
Hudson, TJ
Brooks-Wilson, A
Genest, J
Kastelein, JJ
Hayden, MR
Citation: Sm. Clee et al., Common genetic variation in ABCA1 is associated with altered lipoprotein levels and a modified risk for coronary artery disease, CIRCULATION, 103(9), 2001, pp. 1198-1205
Authors:
Delsing, DJM
Offerman, EH
van Duyvenvoorde, W
van der Boom, H
de Wit, ECM
Gijbels, MJJ
van der Laarse, A
Jukema, JW
Havekes, LM
Princen, HMG
Citation: Djm. Delsing et al., Acyl-CoA: Cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE3-Leiden mice, CIRCULATION, 103(13), 2001, pp. 1778-1786
Authors:
de Man, FH
Weverling-Rijnsburger, AWE
van der Laarse, A
Smelt, AHM
Jukema, JW
Blauw, GJ
Citation: Fh. De Man et al., Not acute but chronic hypertriglyceridemia is associated with impaired endothelium-dependent vasodilation - Reversal after lipid-lowering therapy by atorvastatin, ART THROM V, 20(3), 2000, pp. 744-750
Citation: Pv. Oemrawsingh et al., Clinical and angiographic outcome of stent implantation without predilatation using the Jostent Flex stent, J INVAS CAR, 12(4), 2000, pp. 187-193
Authors:
Lievers, KJA
Mennen, LI
Rattink, AP
Zwinderman, AH
Jukema, JW
Schouten, EG
de Maat, MPM
Citation: Kja. Lievers et al., The-323Ins10 polymorphism for factor VII is not associated with coronary atherosclerosis in symptomatic men, THROMB RES, 97(5), 2000, pp. 275-280
Authors:
Mulder, HJGH
Bal, ET
Jukema, JW
Zwinderman, AH
Schalij, MJ
van Boven, AJ
Bruschke, AVG
Citation: Hjgh. Mulder et al., Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasly (REGRESS trial), AM J CARD, 86(7), 2000, pp. 742-746
Authors:
Hagenaars, T
Gussenhoven, EJ
van Sambeek, MRHM
Jukema, JW
Kranendonk, SE
Bom, N
Citation: T. Hagenaars et al., Effect of Simvastatin on restenosis after percutaneous transluminal angioplasty of femoropopliteal arterial obstruction, AM J CARD, 86(7), 2000, pp. 774-776
Authors:
Schalij, MJ
Udayachalerm, W
Oemrawsingh, P
Jukema, JW
Reiber, JHC
Bruschke, AVG
Citation: Mj. Schalij et al., Stenting of long coronary artery lesions: Initial angiographic results and6-month clinical outcome of the micro stent II-XL, CATHET C IN, 48(1), 1999, pp. 105-112
Citation: Jw. Jukema, Matching treatment to the genetic basis of (lipid) disorder in patients with coronary artery disease, HEART, 82(2), 1999, pp. 126-127
Authors:
Bekedam, MA
Vliegen, HW
Doornbos, J
Jukema, JW
de Roos, A
van der Wall, EE
Citation: Ma. Bekedam et al., Diagnosis and management of anomalous origin of the right coronary artery from the left coronary sinus, INT J CAR I, 15(3), 1999, pp. 253-258
Authors:
Henderson, HE
Kastelein, JJP
Zwinderman, AH
Gagne, E
Jukema, JW
Reymer, PWA
Groenemeyer, BE
Lie, KI
Bruschke, AVG
Hayden, MR
Jansen, H
Citation: He. Henderson et al., Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins, J LIPID RES, 40(4), 1999, pp. 735-743
Authors:
Hallman, DM
Groenemeijer, BE
Jukema, JW
Boerwinkle, E
Kastelein, JJP
Citation: Dm. Hallman et al., Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci, ANN HUM GEN, 63, 1999, pp. 499-510
Authors:
Shepherd, J
Blauw, GJ
Murphy, MB
Cobbe, SM
Bollen, ELEM
Buckley, BM
Ford, I
Jukema, JW
Hyland, M
Gaw, A
Lagaay, AM
Perry, IJ
Macfarlane, PW
Meinders, AE
Sweeney, BJ
Packard, CJ
Westendorp, RGJ
Twomey, C
Scott, DJ
Citation: J. Shepherd et al., The design of a Prospective Study of Pravastatin in the Elderly at Risk (PROSPER), AM J CARD, 84(10), 1999, pp. 1192-1197
Authors:
de Maat, MPM
Jukema, JW
Ye, S
Zwinderman, AH
Moghaddam, PH
Beekman, M
Kastelein, JJP
van Boven, AJ
Bruschke, AVG
Humphries, SE
Kluft, C
Henney, AM
Citation: Mpm. De Maat et al., Effect of the stromelysin-1 promoter on efficacy of pravastatin in coronary atherosclerosis and restenosis, AM J CARD, 83(6), 1999, pp. 852-856
Citation: Jw. Jukema et Ml. Simoons, Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; from the pioneer work of C.D. de Langen to the third "Dutch Consensus on Cholesterol", ACT CARDIOL, 54(3), 1999, pp. 163-168